Our Services

US Oncology affiliated practices gain operational- and cost-efficiencies through our total pharmacy solution:
 
Oncology Pharmaceutical Services

US Oncology minimizes the many challenges associated with pharmaceuticals through its comprehensive Oncology Pharmaceutical Services division. Our extensive range of services enable oncology practices to outsource all aspects of pharmaceutical provision - including purchasing, admixture, onsite pharmacy operation, and utilization reviews - through a total solution that emphasizes operational and cost efficiencies.

With US Oncology, practices leverage the buying power of the nation's largest cancer-care network - a network that purchases over $800 million worth of drugs each year. Practices not only reduce drug acquisition costs, but also significantly decrease losses due to uncompensated treatment and waste. As a result, drug margins are improved and drug management is enhanced.

Affiliated practices can provide a complete range of care in a single convenient facility:

Cancer Center Services

Having developed 77 cancer centers nationwide, US Oncology is the nation's cancer center leader. Practices can benefit greatly from this leadership through our Cancer Center Services division. Our extensive capabilities enable physicians to establish their own freestanding cancer center, integrating all aspects of patient diagnosis and treatment in one convenient, patient-friendly location.

Partnering with physicians throughout the development process, we meet their needs through a family of services that includes everything from financing to pharmaceutical management to operational support. We also assume full responsibility for building and managing their facilities, including the provision of low-cost capital with no personal financial risk. Consequently, physicians are free to focus on their complete continuum of care, retaining control over all patient care decisions.

US Oncology offers access to the nation's largest integrated cancer research platform, bringing oncology trials to local communities:

Cancer Research Services
We are living in an exciting time in medicine and cancer care. yes"  Because of advances in medical and biotechnology sciences, and our understanding of the genetic code, more novel anticancer drugs are in development today than ever before.

Since more than 80 percent of cancer treatment is provided in outpatient community settings, the role of the community oncologist will be critical in testing and bringing these advances to patients rapidly. yes" 

The US Oncology Cancer Research Services division was created exclusively to serve the needs of oncology practices and to bring new clinical trials and novel investigational therapies to their patients. yes"  Through its sole focus on oncology community practices, US Oncology has built one of the nation's largest integrated cancer research networks. yes"  Our mission is to accelerate the development and availability of investigational therapies to community oncologists and their patients.

Today, we support a network of more than 850 community-based oncologists in over 200 research practice locations. yes"  Our goal is to nurture a tightly knit scientific clinical community that operates on a common integrated research platform. yes"  To that end, we have created a single Institutional Review Board, a national scientific process led by physicians, and a state-of-the-art information infrastructure. yes"  All this is supported centrally by an experienced staff of over 120 dedicated research personnel based in Houston and Dallas. 

With more than 80 percent of all cancer care provided in community settings and a market demand estimated at $60 billion, the services of US Oncology have never been more vital.